Platanoside Mitigates Ferroptosis via Keap1-Nrf2/GPX4 Axis in ALI

Study Background and Research Question

Acute lung injury (ALI) is a severe clinical syndrome characterized by dysregulated inflammation, oxidative stress, and breakdown of the alveolar–capillary barrier, with mortality rates reported as high as 30–40% (source: paper). Current therapies, including mechanical ventilation and pharmacological agents targeting inflammation or oxidative stress, have shown limited clinical efficacy due to their single-pathway focus and poor tissue specificity. Ferroptosis, an iron-dependent cell death process driven by lipid peroxidation, has emerged as a central player in the pathogenesis of ALI and other inflammatory diseases. The Keap1–Nrf2/GPX4 signaling axis is crucial for cellular antioxidant defense and ferroptosis regulation, yet its precise therapeutic targeting in ALI remains insufficiently explored. This study investigates whether platanoside, a bioactive flavonoid glycoside, can prevent ferroptosis in ALI by modulating the Keap1–Nrf2/GPX4 pathway via autophagic mechanisms.

Key Innovation from the Reference Study

The central innovation is the discovery that platanoside (PLA) confers robust protection against ferroptosis-driven ALI by directly promoting autophagic degradation of Keap1, a negative regulator of Nrf2. Through this mechanism, PLA lifts Nrf2 repression, leading to upregulation of its downstream antioxidant target GPX4 and effective suppression of lipid peroxidation. Mechanistic insights reveal that PLA enhances SQSTM1/p62-mediated Keap1–p62 complex formation, facilitating selective autophagy of Keap1 and thus enabling sustained Nrf2/GPX4 axis activation (source: paper). This dual-layered regulatory strategy provides a new paradigm for targeting ferroptosis and oxidative stress in lung injury and potentially other redox-mediated pathologies.

Methods and Experimental Design Insights

The study utilized a combination of in vivo and in vitro approaches:

• ALI Mouse Model: Lipopolysaccharide (LPS)-induced ALI was established in mice to mimic clinical oxidative lung injury conditions. PLA was administered and compared with vehicle controls.
• Molecular Analyses: Western blotting and immunohistochemistry were used to quantify Keap1, Nrf2, GPX4, and ferroptosis markers (4-hydroxynonenal, malondialdehyde) in lung tissues.
• Subcellular Localization: Nrf2 nuclear translocation was visualized to assess pathway activation.
• Autophagy Pathway Interrogation: Co-immunoprecipitation and confocal microscopy demonstrated enhanced Keap1–p62 complex formation, providing evidence for autophagy-dependent Keap1 degradation.
• Histological and Ultrastructural Assessment: Hematoxylin-eosin staining and transmission electron microscopy evaluated lung tissue integrity and mitochondrial morphology.

These experimental layers allowed the authors to connect PLA’s biochemical effects with functional outcomes in ALI pathology (source: paper).

Protocol Parameters

• ALI mouse model | LPS 5 mg/kg i.p. | ALI induction | Standard for robust acute injury | paper
• PLA treatment | 30 mg/kg i.p. | Protective efficacy in ALI | Dose confirmed to reduce ferroptosis markers and tissue injury | paper
• Superoxide/lipid peroxidation assay | 4-HNE, MDA immunostaining | Ferroptosis quantification | Validated markers of oxidative injury in tissue | paper
• DHE (hydroethidine) superoxide probe | 1–5 μM (suggested) | Live-cell ROS measurement | Recommended for quantitative oxidative stress assays in similar models | workflow_recommendation

Core Findings and Why They Matter

PLA administration in LPS-induced ALI mice led to a marked reduction in Keap1 protein levels and facilitated Nrf2 nuclear translocation, with a corresponding increase in GPX4 expression and enzymatic activity (source: paper). Importantly, PLA significantly decreased levels of ferroptosis markers—4-hydroxynonenal and malondialdehyde—attenuated mitochondrial damage, and improved histological lung injury scores. Mechanistically, PLA enhanced the interaction between Keap1 and p62/SQSTM1, promoting selective autophagic degradation of Keap1. This effect underlies the restoration of redox homeostasis and the suppression of ferroptosis. The study demonstrates that targeting upstream regulators of Nrf2—specifically via autophagy-mediated Keap1 degradation—offers a multifaceted approach to reducing oxidative stress, inflammation, and cell death in ALI. This insight not only advances understanding of ALI pathophysiology but also highlights a generalizable mechanism with potential relevance for other oxidative stress-driven diseases.

Comparison with Existing Internal Articles

Several recent internal resources have explored the use of Dihydroethidium (DHE, hydroethidine) as a gold-standard probe for intracellular superoxide detection and oxidative stress assay development:

• One article (internal article) details how DHE empowers researchers to interrogate oxidative stress and apoptosis mechanisms in live-cell models, providing a translational bridge to disease-focused research. This aligns with the present study’s emphasis on quantifying ROS and lipid peroxidation as central readouts of ferroptosis and therapeutic efficacy.
• Another thought-leadership piece (internal article) specifically mentions the Keap1–Nrf2/GPX4 axis in acute lung injury, offering workflow recommendations for robust, reproducible ROS measurement using DHE. This dovetails with the present study’s mechanistic focus and supports the use of DHE-based assays as a complementary readout to biochemical and histological endpoints.
• Further benchmarking in (internal article) situates DHE as a frontline tool for redox biology, particularly in cardiovascular and cancer models, demonstrating its transferability across disease contexts where oxidative stress is a pathogenic driver.

These internal resources collectively reinforce the study’s methodological rigor and highlight the centrality of reliable ROS detection in advancing translational redox research.

Limitations and Transferability

Despite the compelling mechanistic data and therapeutic promise, several limitations merit consideration:

• Model Specificity: The findings are based on an LPS-induced mouse model of ALI, which, while widely used, does not fully recapitulate the complexity of human disease (source: paper).
• Cell-Type Resolution: Although the study implicates alveolar epithelial cells, the precise cellular targets and off-target effects of PLA require further delineation.
• Long-Term Outcomes: The sustainability of Keap1–Nrf2/GPX4 axis modulation and the long-term safety of PLA administration were not addressed.
• Transferability: While the Keap1–Nrf2/GPX4 pathway is relevant in other oxidative stress-related disorders, direct evidence for PLA’s efficacy beyond ALI is lacking and will require additional validation (source: paper).

Research Support Resources

For researchers aiming to investigate oxidative stress, ferroptosis, or redox signaling in ALI and related disease models, robust intracellular reactive oxygen species measurement is essential. Dihydroethidium (DHE) (hydroethidine, SKU C3807) from APExBIO is a validated, cell-permeable fluorescent probe enabling quantitative superoxide detection and oxidative stress assays in live cells. DHE-based protocols, as discussed in internal benchmarking articles, can support the workflow for mechanistic studies involving the Keap1–Nrf2/GPX4 axis or apoptosis research. For protocol guidance and technical specifications, refer to the manufacturer’s documentation and recent workflow recommendations (source: internal article).